[Relations between blood polymorphism and uterine carcinoma].
In a study of 63 female patients with cervical carcinoma and 37 with corpus carcinoma (all patients from Hamburg), polymorphisms of the blood were determined, which have not previously or only rarely been studied in such patients. Comparisons with a control group revealed no significant differences for the MNSs, P, Jk, SEP, PGM, GPT, EsD, Hp, Gc, and Gm systems. The patients with corpus carcinoma, however, exhibited a lesser frequency of Ccee and an increased frequency of homozygotes in the Fy system. Furthermore, the proportion of patients with GLO1 was greater among the women with cervix carcinoma.
D000941:Antigens / Q000032:analysis; D001789:Blood Group Antigens / Q000235:genetics* / Q000276:immunology; D002277:Carcinoma / Q000097:blood*; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006801:Humans; D010641:Phenotype; D011110:Polymorphism, Genetic; D002583:Uterine Cervical Neoplasms / Q000097:blood; D014594:Uterine Neoplasms / Q000097:blood*
D000941:Antigens; D001789:Blood Group Antigens
Zur Frage nach Zusammenhängen zwischen Polymorphismen des Blutes und Uterus-Karzinomen.